Mark J. Enyedy
2021
In 2021, Mark J. Enyedy earned a total compensation of $7.4M as President and Chief Executive Officer at ImmunoGen, a 62% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $498,996 |
|---|---|
| Option Awards | $6,196,432 |
| Salary | $735,407 |
| Other | $9,672 |
| Total | $7,440,507 |
Enyedy received $6.2M in option awards, accounting for 83% of the total pay in 2021.
Enyedy also received $499K in non-equity incentive plan, $735.4K in salary and $9.7K in other compensation.
Rankings
In 2021, Mark J. Enyedy's compensation ranked 1,599th out of 12,415 executives tracked by ExecPay. In other words, Enyedy earned more than 87.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,599 out of 12,415 | 87th |
Division Manufacturing | 582 out of 5,505 | 89th |
Major group Chemicals And Allied Products | 216 out of 2,375 | 91st |
Industry group Drugs | 181 out of 2,096 | 91st |
Industry Pharmaceutical Preparations | 122 out of 1,546 | 92nd |
Pay ratio
| Mark J. Enyedy's Pay | $7,440,507 |
|---|---|
| Median Employee's Pay | $296,859 |
| Pay Ratio | 25to 1 |
In 2021, the annual total compensation of Mark J. Enyedy was $7,440,507.
The annual total compensation of the median employee at ImmunoGen was $296,859.
The ratio of Mark J. Enyedy's pay to the pay of median employee was therefore 25 to one.
Source: SEC filing on April 26, 2022.
Enyedy's colleagues
We found four more compensation records of executives who worked with Mark J. Enyedy at ImmunoGen in 2021.